Odanacatib - CAS# 603139-19-1 275 and reduced brain atrophy

and reduced brain atrophy

6-dimethyl-2-oxo-1

RGFP966 was dosed to mice at 10 mg/Kg once per day by subcutaneous dosing

Specific inhibitors of the breast cancer resistance protein (BCRP)

OC(=O)C(F)(F)F

Odanacatib - CAS# 603139-19-1 275 and reduced brain atrophyOdanacatib, also known as MK 0822, CAS No. 603139 19 1, is an inhibitor of cathepsin K with potential anti osteoporotic activity. Odanacatib selectively binds to and inhibits the activity of cathepsin K, which may result in a reduction in bone resorption, improvement of bone mineral density, and a reversal in osteoporotic changes. Cathepsin K, a tissue specific cysteine protease that catalyzes degradation of bone matrix proteins such as collagen I II,